vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.
Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). Shoals Technologies Group, Inc. runs the higher net margin — 5.5% vs 3.3%, a 2.2% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-11.3M). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.
NATR vs SHLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $148.3M |
| Net Profit | $4.1M | $8.1M |
| Gross Margin | 72.5% | 31.6% |
| Operating Margin | 4.3% | 11.7% |
| Net Margin | 3.3% | 5.5% |
| Revenue YoY | 4.7% | 38.6% |
| Net Profit YoY | 1379.4% | 3.9% |
| EPS (diluted) | $0.23 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $148.3M | ||
| Q3 25 | $128.3M | $135.8M | ||
| Q2 25 | $114.8M | $110.8M | ||
| Q1 25 | $113.2M | $80.4M | ||
| Q4 24 | $118.2M | $107.0M | ||
| Q3 24 | $114.6M | $102.2M | ||
| Q2 24 | $110.6M | $99.2M | ||
| Q1 24 | $111.0M | $90.8M |
| Q4 25 | $4.1M | $8.1M | ||
| Q3 25 | $5.3M | $11.9M | ||
| Q2 25 | $5.3M | $13.9M | ||
| Q1 25 | $4.7M | $-282.0K | ||
| Q4 24 | $-321.0K | $7.8M | ||
| Q3 24 | $4.3M | $-267.0K | ||
| Q2 24 | $1.3M | $11.8M | ||
| Q1 24 | $2.3M | $4.8M |
| Q4 25 | 72.5% | 31.6% | ||
| Q3 25 | 73.3% | 37.0% | ||
| Q2 25 | 71.7% | 37.2% | ||
| Q1 25 | 72.1% | 35.0% | ||
| Q4 24 | 72.0% | 37.6% | ||
| Q3 24 | 71.3% | 24.8% | ||
| Q2 24 | 71.4% | 40.3% | ||
| Q1 24 | 71.2% | 40.2% |
| Q4 25 | 4.3% | 11.7% | ||
| Q3 25 | 7.0% | 13.7% | ||
| Q2 25 | 3.7% | 14.4% | ||
| Q1 25 | 5.4% | 5.4% | ||
| Q4 24 | 3.8% | 15.4% | ||
| Q3 24 | 4.6% | 4.4% | ||
| Q2 24 | 5.1% | 18.7% | ||
| Q1 24 | 4.2% | 12.8% |
| Q4 25 | 3.3% | 5.5% | ||
| Q3 25 | 4.2% | 8.7% | ||
| Q2 25 | 4.6% | 12.5% | ||
| Q1 25 | 4.2% | -0.4% | ||
| Q4 24 | -0.3% | 7.3% | ||
| Q3 24 | 3.8% | -0.3% | ||
| Q2 24 | 1.2% | 11.9% | ||
| Q1 24 | 2.1% | 5.3% |
| Q4 25 | $0.23 | $0.05 | ||
| Q3 25 | $0.30 | $0.07 | ||
| Q2 25 | $0.28 | $0.08 | ||
| Q1 25 | $0.25 | $0.00 | ||
| Q4 24 | $-0.02 | $0.04 | ||
| Q3 24 | $0.23 | $0.00 | ||
| Q2 24 | $0.07 | $0.07 | ||
| Q1 24 | $0.12 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $7.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $600.0M |
| Total Assets | $261.1M | $904.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $7.3M | ||
| Q3 25 | $95.6M | $8.6M | ||
| Q2 25 | $81.3M | $4.7M | ||
| Q1 25 | $86.5M | $35.6M | ||
| Q4 24 | $84.7M | $23.5M | ||
| Q3 24 | $78.7M | $11.1M | ||
| Q2 24 | $68.7M | $3.2M | ||
| Q1 24 | $77.8M | $15.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $141.8M | ||
| Q4 24 | — | $141.8M | ||
| Q3 24 | — | $141.8M | ||
| Q2 24 | — | $146.8M | ||
| Q1 24 | $2.1M | $168.8M |
| Q4 25 | $161.6M | $600.0M | ||
| Q3 25 | $166.7M | $589.6M | ||
| Q2 25 | $163.7M | $575.4M | ||
| Q1 25 | $167.1M | $558.9M | ||
| Q4 24 | $161.0M | $556.8M | ||
| Q3 24 | $162.6M | $545.2M | ||
| Q2 24 | $156.4M | $544.6M | ||
| Q1 24 | $159.7M | $554.0M |
| Q4 25 | $261.1M | $904.1M | ||
| Q3 25 | $264.8M | $851.8M | ||
| Q2 25 | $254.9M | $795.0M | ||
| Q1 25 | $252.7M | $788.4M | ||
| Q4 24 | $240.9M | $793.1M | ||
| Q3 24 | $245.3M | $801.3M | ||
| Q2 24 | $235.8M | $788.4M | ||
| Q1 24 | $247.3M | $825.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | 0.01× | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $-4.1M |
| Free Cash FlowOCF − Capex | $7.6M | $-11.3M |
| FCF MarginFCF / Revenue | 6.1% | -7.6% |
| Capex IntensityCapex / Revenue | 1.9% | 4.8% |
| Cash ConversionOCF / Net Profit | 2.41× | -0.50× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $-4.1M | ||
| Q3 25 | $18.5M | $19.4M | ||
| Q2 25 | $4.3M | $-13.8M | ||
| Q1 25 | $2.6M | $15.6M | ||
| Q4 24 | $12.2M | $14.0M | ||
| Q3 24 | $9.6M | $15.7M | ||
| Q2 24 | $1.3M | $37.8M | ||
| Q1 24 | $2.2M | $12.9M |
| Q4 25 | $7.6M | $-11.3M | ||
| Q3 25 | $16.8M | $9.0M | ||
| Q2 25 | $3.0M | $-26.0M | ||
| Q1 25 | $1.5M | $12.3M | ||
| Q4 24 | $10.0M | $12.5M | ||
| Q3 24 | $7.9M | $13.3M | ||
| Q2 24 | $-2.0M | $35.8M | ||
| Q1 24 | $-1.5M | $10.4M |
| Q4 25 | 6.1% | -7.6% | ||
| Q3 25 | 13.1% | 6.6% | ||
| Q2 25 | 2.6% | -23.5% | ||
| Q1 25 | 1.3% | 15.4% | ||
| Q4 24 | 8.5% | 11.6% | ||
| Q3 24 | 6.9% | 13.0% | ||
| Q2 24 | -1.9% | 36.1% | ||
| Q1 24 | -1.4% | 11.4% |
| Q4 25 | 1.9% | 4.8% | ||
| Q3 25 | 1.3% | 7.7% | ||
| Q2 25 | 1.2% | 11.0% | ||
| Q1 25 | 1.0% | 4.0% | ||
| Q4 24 | 1.9% | 1.4% | ||
| Q3 24 | 1.5% | 2.3% | ||
| Q2 24 | 3.0% | 2.0% | ||
| Q1 24 | 3.3% | 2.7% |
| Q4 25 | 2.41× | -0.50× | ||
| Q3 25 | 3.46× | 1.63× | ||
| Q2 25 | 0.81× | -1.00× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | 3.21× | ||
| Q1 24 | 0.94× | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SHLS
| System Solutions | $122.0M | 82% |
| Components | $26.3M | 18% |
